Bdparib 300 mg contains Rucaparib, a PARP inhibitor used to treat certain prostate and ovarian cancers. It works by blocking PARP enzymes, preventing cancer cells from repairing damaged DNA and slowing their growth. Take it exactly as directed by your healthcare provider. Common side effects may include nausea, fatigue, anemia, vomiting, constipation, decreased appetite, and changes in liver function tests. Active Ingredient (Generic Name): Rucaparib Indication: Treatment of Prostate and Ovarian Cancers Manufacturer: BDR Pharmaceuticals Packaging: 60 Tablets in bottle Strength 300mg Delivery Time: 6 To 15 days


Acabrunat 100 mg (Acalabrutinib)
Acalabrutinib 100 Mg Australia
Afatinib Dimaleate 50 mg Australia